Shalby
Ticker > Company >

Shalby share price

Shalby Ltd.

NSE: SHALBY BSE: 540797 SECTOR: Hospital & Healthcare Services  64k   120   21

203.30
+3.38 (1.69%)
NSE: Today, 11:14 AM

Price Summary

Today's High

₹ 205.8

Today's Low

₹ 197.86

52 Week High

₹ 325

52 Week Low

₹ 177.45

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2195.84 Cr.

Enterprise Value

₹ 2300.64 Cr.

No. of Shares

10.8 Cr.

P/E

24.07

P/B

1.96

Face Value

₹ 10

Div. Yield

0.59 %

Book Value (TTM)

₹  103.6

CASH

₹ 9.23 Cr.

DEBT

₹ 114.02 Cr.

Promoter Holding

74.27 %

EPS (TTM)

₹  8.45

Sales Growth

17.18%

ROE

10.23 %

ROCE

14.97%

Profit Growth

28.51 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year17.18%
3 Year25.61%
5 Year12.4%

Profit Growth

1 Year28.51%
3 Year34.29%
5 Year26.47%

ROE%

1 Year10.23%
3 Year8.93%
5 Year7.08%

ROCE %

1 Year14.97%
3 Year13.08%
5 Year10.69%

Debt/Equity

0.1074

Price to Cash Flow

15.71

Interest Cover Ratio

37.6885

CFO/PAT (5 Yr. Avg.)

1.65858824325031

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 74.27 0.00
Dec 2024 74.27 0.00
Sep 2024 74.25 0.00
Jun 2024 74.25 0.00
Mar 2024 74.24 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 34.289978613002% for the Past 3 years.
  • The company has shown a good revenue growth of 25.6066998821934% for the Past 3 years.
  • Company has a healthy Interest coverage ratio of 37.6885.
  • Company’s PEG ratio is 0.848064352656854.
  • The company has an efficient Cash Conversion Cycle of -2571.7751 days.
  • Company has a healthy liquidity position with current ratio of 3.9925.
  • The company has a good cash flow management; CFO/PAT stands at 1.65858824325031.
  • The company has a high promoter holding of 74.27%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 195.15 206.32 232.72 212.27 220.64
Total Expenditure 151.94 168.07 182.19 176.81 178.11
Operating Profit 43.21 38.26 50.53 35.46 42.53
Other Income 5.21 4.37 7.52 5.29 6.28
Interest 0.61 0.99 2.67 2.7 3.09
Depreciation 9.33 9.12 9.54 9.78 9.94
Exceptional Items 0 0 0 0 0
Profit Before Tax 38.48 32.52 45.84 28.28 35.77
Tax 13.76 9.96 15.37 10.95 14.91
Profit After Tax 24.72 22.56 30.47 17.33 20.86
Adjusted EPS (Rs) 2.3 2.1 2.83 1.61 1.94

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 483.89 418.67 646.8 708.02 829.68
Total Expenditure 401.33 331.63 515.54 564.72 650.69
Operating Profit 82.56 87.04 131.26 143.3 179
Other Income 17.74 9.62 13 19.57 20.7
Interest 7.41 4.5 4.4 4.44 4.32
Depreciation 35.86 36.67 35.5 37.07 37.08
Exceptional Items 0 0 -4.44 0 0
Profit Before Tax 57.03 55.49 99.92 121.36 158.31
Tax 29.06 12.61 30.11 40.55 54.47
Net Profit 27.97 42.88 69.81 80.81 103.85
Adjusted EPS (Rs.) 2.59 3.97 6.46 7.53 9.67

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 108.01 108.01 108.01 107.31 107.41
Total Reserves 705.78 741.64 798.71 863.01 954.76
Borrowings 48.67 35.5 25.33 14.61 103.12
Other N/C liabilities 95.89 114.47 146.44 185.04 211.06
Current liabilities 83.25 82.37 97.31 105.01 108.16
Total Liabilities 1041.6 1081.99 1175.8 1274.98 1484.51
Assets
Net Block 669.82 657.58 628.18 602.83 599.28
Capital WIP 3.02 3.99 4.48 5.67 5.24
Intangible WIP 3.37 3.53 1.25 4.38 0
Investments 10.65 11.79 36.6 74.9 280.82
Loans & Advances 110.72 120.3 145.41 172.74 166.01
Other N/C Assets 3.37 7.61 2.57 1.53 1.33
Current Assets 240.65 277.2 357.31 412.93 431.82
Total Assets 1041.6 1081.99 1175.8 1274.98 1484.51
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 57.03 55.49 99.92 121.36 158.31
Adjustment 36.82 36.75 41.29 27.59 26.31
Changes in Assets & Liabilities -16.75 -5.76 -17.48 42.65 -25.09
Tax Paid -20.02 -9.24 -22.81 -27.07 -19.77
Operating Cash Flow 57.09 77.24 100.93 164.53 139.77
Investing Cash Flow -32.28 -51.83 -40.32 -172.4 -206.01
Financing Cash Flow -21.5 -27.82 -17.25 -38.21 72.14
Net Cash Flow 3.31 -2.41 43.36 -46.09 5.91

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 74.24 74.25 74.25 74.27 74.27
darshini vikram shah 2.79 2.79 2.79 2.79 2.79
shah family trust throuh ... 34.73 34.73 34.73 34.73 34.73
shanay vikram shah 0.13 0.13 0.13 0.13 0.13
vikram indrajit shah 7.38 7.39 7.39 7.41 7.41
zodiac mediquip limited 29.21 29.21 29.21 29.21 29.21
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 25.88 25.88 25.88 25.76 25.75
polus global fund 1.03 1.03 1.03 1.03 1.03
kifs international llp 1.06 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Shalby informs about scrutinizers report 15 Mar, 4:06 PM Shalby informs about notice of postal ballot 10 Feb, 5:17 PM Shalby - Quaterly Results 3 Feb, 7:36 PM Shalby - Quaterly Results 3 Feb, 7:36 PM Shalby launches Tissue & Bone Bank at Krishna Shalby Hospital, Ahmedabad 16 Jan, 3:57 PM Shalby’s step down arm receives USFDA’s approval for Duraniom 16 Jan, 11:09 AM Shalby informs about earnings call transcript 6 Nov, 3:10 PM Shalby - Quaterly Results 30 Oct, 12:35 PM Shalby - Quaterly Results 30 Oct, 12:35 PM Shalby - Quaterly Results 30 Oct, 12:35 PM Shalby informs about earnings conference call 25 Oct, 12:18 PM Shalby informs about updates 3 Oct, 5:30 PM Shalby opens Orthopedics Centre of Excellence in Rajkot 5 Aug, 9:20 AM Shalby informs about exercise of stock option under ESOS 22 Jul, 4:57 PM Shalby to execute lease agreement to construct new healthcare facility in Mumbai 11 Jul, 12:14 PM Shalby - Quaterly Results 8 Jul, 1:41 PM Shalby - Quaterly Results 8 Jul, 1:41 PM Shalby - Quaterly Results 8 Jul, 1:41 PM Shalby informs about change in mode of investor call 5 Jul, 11:59 AM Shalby informs about investor conference call 2 Jul, 11:37 AM Shalby informs about trading window closure 26 Jun, 4:30 PM Shalby informs about disclosure 6 Jun, 1:06 PM Shalby - Quaterly Results 28 May, 2:42 PM Shalby - Quaterly Results 28 May, 2:42 PM Shalby’s step-down arm incorporates Wholly-Owned Subsidiary in India 12 Apr, 9:26 AM Shalby informs about compliance certificate 3 Apr, 5:22 PM Shalby informs about compliance certificate 2 Apr, 3:05 PM Shalby to avail term loan facility from Bajaj Finance to acquire Healers Hospital 15 Mar, 11:09 AM Shalby to acquire 100% equity stake in Healers Hospital 13 Mar, 10:15 AM Shalby submits intimation of grant of options under Shalby ESOS - 2021 7 Feb, 5:23 PM Shalby - Quaterly Results 7 Feb, 2:27 PM Shalby - Quaterly Results 7 Feb, 2:27 PM Shalby - Quaterly Results 7 Feb, 2:27 PM Shalby acquires majority stake in Sanar International hospitals 18 Jan, 4:23 PM Shalby’s healthcare education division signs MoU with Kaushalya 11 Jan, 6:15 PM Shalby informs about compliances-certificate 3 Jan, 4:45 PM Shalby’s arm gets nod to invest in Shalby Global Technologies 18 Dec, 2:37 PM Shalby gets nod for availing of enhanced renewed SBLC facility 13 Dec, 11:21 AM Shalby informs about change in senior management 28 Nov, 2:50 PM Shalby executes amendment agreement for hospital building in Mumbai 23 Nov, 10:57 AM Shalby informs about disclosure 22 Nov, 5:29 PM Shalby informs about investor presentation 28 Oct, 12:22 PM Shalby informs about press release 28 Oct, 12:17 PM Shalby - Quaterly Results 27 Oct, 12:31 PM Shalby - Quaterly Results 27 Oct, 12:31 PM Shalby - Quaterly Results 27 Oct, 12:31 PM Shalby informs about analyst meet 20 Oct, 4:56 PM Shalby informs about analyst meet 15 Sep, 2:26 PM Shalby inaugurates 60 bed hospital at Ranchi 7 Aug, 10:08 AM Shalby informs about AGM 21 Jul, 2:42 PM

Shalby Stock Price Analysis and Quick Research Report. Is Shalby an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Shalby and its performance over the period of time. Shalby stock price today is Rs 203.3.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Shalby cash from the operating activity was Rs 139.772 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Shalby has a Debt to Equity ratio of 0.1074 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Shalby , the EPS growth was 28.3853 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Shalby has OPM of 21.5741433776515 % which is a good sign for profitability.
     
  • ROE: Shalby have a average ROE of 10.2267 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Shalby is Rs 203.3. One can use valuation calculators of ticker to know if Shalby share price is undervalued or overvalued.
Last Updated on:
Brief about Shalby

Shalby Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Shalby Ltd. is a leading healthcare service provider in India. Established in 1994 by Dr. Vikram I. Shah, a renowned orthopedic surgeon, the company has grown to become one of the largest multi-specialty hospitals in the country. With a focus on excellence in patient care and advanced medical treatments, Shalby Ltd. has gained a reputation for its quality services in various healthcare disciplines.

Shalby Ltd. - Share Price

At our website, you can easily track the real-time and historical share prices of Shalby Ltd. Our pre-built screening tools provide a convenient way to analyze the company's stock performance and compare it with industry peers. Whether you are a long-term investor or simply interested in monitoring the stock, you can rely on our comprehensive share price data.

Shalby Ltd. - Balance Sheet

The balance sheet of Shalby Ltd. provides an insight into the company's financial position, assets, and liabilities. By studying the balance sheet, investors can evaluate the company's solvency, liquidity, and capital structure. Our website offers downloadable annual reports that include the detailed balance sheet information for Shalby Ltd. Additionally, our premium features allow users to perform fair value calculations using tools like DCF (Discounted Cash Flow) Analysis and BVPS (Book Value per Share) Analysis.

Shalby Ltd. - Annual Report

The annual report of Shalby Ltd. provides a comprehensive review of the company's performance, achievements, and future growth prospects. Investors can gain valuable insights into the company's financials, strategic initiatives, and market outlook through these reports. Our website offers annual reports as downloadable files, making it convenient for users to access and analyze the information.

Shalby Ltd. - Dividend

Dividends are an important aspect for investors considering long-term stock investments. The dividend policy of Shalby Ltd. is aimed at rewarding shareholders for their investment. By studying the company's dividend history, investors can assess the stability and growth of the dividend payments. Our website provides detailed dividend information for Shalby Ltd., enabling users to analyze the company's dividend policy and track dividend announcements.

Shalby Ltd. - Quarterly Results

Quarterly results are important indicators of a company's financial performance and its ability to meet targets. At our website, users can access the quarterly results of Shalby Ltd. and analyze key financial metrics such as revenues, profits, and margins. Our premium features allow users to perform fair value calculations using tools like Earnings Multiple Approach and DuPont Analysis, which can provide a deeper understanding of the company's financial health and performance.

Shalby Ltd. - Stock Price

Tracking the stock price of Shalby Ltd. is essential for investors to make informed investment decisions. Our website offers real-time stock price information along with historical data. Users can analyze price trends, patterns, and volatility through our comprehensive price charts. Our pre-built screening tools can help investors assess the stock's performance relative to market benchmarks and industry peers.

Shalby Ltd. - Price Chart

Our website provides detailed price charts for Shalby Ltd., allowing users to visualize the stock's performance over time. Whether you are analyzing short-term price fluctuations or long-term trends, our interactive charts offer a comprehensive view of the stock's price movements. By using our pre-built screening tools, users can identify potential investment opportunities based on technical analysis and trend indicators.

Shalby Ltd. - News

Staying updated with the latest news about Shalby Ltd. is crucial for investors. Our website provides a dedicated news section where users can access the latest developments, announcements, and market news related to the company. Whether it's news about expansion plans, new partnerships, or regulatory updates, users can rely on our platform to stay informed about Shalby Ltd.

Shalby Ltd. - Concall Transcripts

Concall transcripts offer valuable insights into the discussions and deliberations during the company's conference calls with analysts and investors. Our website provides downloadable concall transcripts for Shalby Ltd., allowing users to gain firsthand knowledge about the company's performance, strategies, and management outlook. These transcripts enable investors to make informed decisions based on the analysis of management discussions and market commentary.

Shalby Ltd. - Investor Presentations

Investor presentations are an effective way for companies to communicate their vision, strategy, and financial performance to investors. Our website offers downloadable investor presentations for Shalby Ltd., providing users with in-depth information about the company's business model, growth prospects, and market positioning. By studying these presentations, investors can gain a better understanding of the company's value proposition and make informed investment decisions.

Shalby Ltd. - Promoters

The promoters of Shalby Ltd. play a crucial role in the company's growth and success. Our website provides comprehensive information about the promoters of Shalby Ltd, including their background, experience, and contribution to the company's development. Investors can evaluate the credibility and expertise of the promoters, which can influence their investment decisions.

Shalby Ltd. - Shareholders

Understanding the shareholder base of Shalby Ltd. can provide insights into the company's ownership structure and investor sentiment. Our website offers information about the major shareholders of Shalby Ltd., including institutional investors and individual shareholders. Investors can analyze the shareholding pattern and changes in ownership, which can be useful in assessing market perception and potential voting rights in the company.

By providing comprehensive information about Shalby Ltd.'s company profile, share price, balance sheet, annual report, dividend, quarterly results, stock price, price chart, news, concall transcripts, investor presentations, promoters, and shareholders, our website aims to cater to the needs of long-term stock investors seeking detailed stock analysis. We also offer premium features that allow fair value calculation using tools like DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis. Users can access and download annual reports, concall transcripts, investor presentations, credit ratings, and research reports to make well-informed investment decisions. 

Shalby Balance Sheet Overview

In the comprehensive analysis of Shalby's balance sheet from March 2020 to March 2024, we observe a steady increase in Total Liabilities and Assets, signifying growth. Examining the individual components provides deeper insights into the company's financial health and strategic positioning.

Shalby's Equity and Reserves

The Share Capital of Shalby shows a slight modification, moving from Rs 108.01 Cr. in March 2020 to Rs 107.41 Cr. in March 2024. However, a significant increase in Total Reserves from Rs 705.78 Cr. to Rs 954.76 Cr. during the same period highlights the company's ability to accumulate profits and reinforce its financial foundation.

Shalby's Debt Analysis

Looking at Shalby's borrowings, there was a noteworthy reduction from Rs 48.67 Cr. in March 2020 to Rs 14.61 Cr. in March 2023, before a sharp increase to Rs 103.12 Cr. in March 2024. This fluctuation warrants a close watch for understanding the company's debt management strategy.

Shalby's Assets Insight

The Net Block has seen a gradual decrease, suggesting asset depreciation or disposals; from Rs 669.82 Cr. in 2020 to Rs 599.28 Cr. in 2024. On the other hand, Investments surged impressively to Rs 280.82 Cr. from a mere Rs 10.65 Cr., indicating strategic asset reallocation or investment activities.

Moreover, the Current Assets growth, from Rs 240.65 Cr. in March 2020 to Rs 431.82 Cr. in March 2024, showcases robust operational efficiency and liquidity management.

This data reflects an analysis for the Standalone Balance Sheet of the company, equipping investors with critical insights for a comprehensive stock screening process.

Additionally, Shalby's evolving financials play a significant role in the healthcare sector's dynamics on platforms like NSE and BSE, influencing investor sentiments across the spectrum.

Read More
X